Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Pieber, TR; Aronson, R; Christiansen, MP; Bode, B; Junaidi, K; Conoscenti, V.
Efficacy, safety, tolerability, and noninferiority phase 3 study of glucagon as a ready-to-use room temperature liquid stable formulation versus a lyophilised formulation for the biochemical recovery and symptomatic relief of insulin-induced severe hypoglycaemia in adults with type 1 diabetes.
Diabetes Obes Metab. 2022; 24(7):1394-1397
Doi: 10.1111/dom.14699
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Pieber Thomas
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Find related publications in this database (using NLM MeSH Indexing)
-
Adult - administration & dosage
-
Blood Glucose - administration & dosage
-
Diabetes Mellitus, Type 1 - drug therapy
-
Glucagon - adverse effects
-
Humans - administration & dosage
-
Hypoglycemia - chemically induced, prevention & control
-
Hypoglycemic Agents - adverse effects
-
Insulin - adverse effects
-
Temperature - administration & dosage
- Find related publications in this database (Keywords)
-
glucagon
-
severe hypoglycaemia
-
type 1 diabetes